Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ROCKWELL MEDICAL, INC. (RMTI)

Rockwell Medical Q2 sales rise 11% to $17.8 million; net loss narrows to $1.2 million

Positive Impact 3 of 5 earnings Written later

Rockwell Medical reported second-quarter 2026 results on August 13, 2026. Net sales rose 11% to $17.8 million from $16.1 million a year earlier, and the net loss narrowed to $1.2 million from $1.5 million. The company reiterated its full-year 2026 guidance, including net sales of $70.0 million to $75.0 million.

Key points

  • Q2 2026 net sales were $17.8 million, up 11% from $16.1 million in Q2 2025.
  • Net loss for the quarter was $1.2 million, or $(0.34) per share, versus a net loss of $1.5 million, or $(0.48) per share, a year earlier.
  • Gross margin was 18%, up from 16% a year earlier; cash and investments were $24.8 million at June 30, 2026.
  • 2026 guidance reiterated: net sales $70.0 million to $75.0 million, gross margin 18% to 22%, Adjusted EBITDA $1.0 million to $2.0 million, and positive operating cash flow.

The filing

CompanyROCKWELL MEDICAL, INC. (RMTI)
Form8-K, current report
Filed with the SECAug 13, 2026, 6:14 AM ET
Accession number0001628280-26-056454

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.